At Celnova Pharma we are interested in developing our business through the representation of original products, biosimilars and complex generics in Latin America.
Celnova was designed from day one to be a suitable partner for multinational companies.
This is why we seek to establish long-term relationships with multinational companies through licensing or co-marketing agreements to provide their products to patients in the region.
As a partner, Celnova offers the following capabilities:
- Compliance: our own compliance code strengthened by integrating policies from our strategic partners.
- Local Infrastructure and Regulatory: local regulatory approvals and permits allowing us to register, import, and commercialize drugs and medical devices in five countries.
- Market Entry: we have capabilities and experience in market sizing, enabling us to develop and implement strategies to enter and stand out in new markets.
- Regulatory and Pharmacovigilance: experienced in-house regulatory team, based in Buenos Aires, coordinating submissions throughout the region, ensuring optimal regulatory compliance.
- Local Relationships: constant interaction with health and regulatory authorities in each country, facilitating registration, importation, and reimbursement processes.
- Medical Affairs: medical team covering Argentina, Chile, Peru, Colombia, Ecuador, Uruguay, and Bolivia.
- Patient-Centricity: Patient Support Program managed by third parties. Possibility of conducting genetic tests. Frequent collaboration with patient organizations.
- Sales, Marketing, and Distribution: internal sales and marketing teams supported by digital activities. Distribution through specialized local third parties.
- Market Access: market access functions led by Senior Management and business unit leaders.
- Alliance Management: monitoring of our alliances, including product registration status, pre-launch and post-launch activities, ensuring successful and enduring collaboration.